Acute coronary syndrome (ACS) remains a significant contributor to morbidity and mortality, accounting for approximately 15% of New Zealand’s annual deaths, with mortality rates exceeding those of many Western countries.
Full article available to subscribers
Acute coronary syndrome (ACS) remains a significant contributor to morbidity and mortality, accounting for approximately 15% of New Zealand’s annual deaths, with mortality rates exceeding those of many Western countries.1
Neurological conditions, including stroke and intracranial haemorrhage (ICH), can mimic the presentation of ACS with ST-elevation on electrocardiogram (ECG), without obstructive coronary disease.2,3 Seizures presenting with acute ST-elevation is much more rarely described. While the pathophysiology remains unclear, understanding the potential causes of ST-elevation myocardial infarction (STEMI) with non-obstructive coronary arteries is important for making a diagnosis and determining further management.4 Here we present a rare case of seizures mimicking an ACS, presenting with ST-elevation with normal coronary arteries.
A 21-year-old epileptic man with poor medication compliance presented following five successive seizures over a period of hours without full recovery. He was initially unresponsive with a low-grade fever, but haemodynamically stable with normal cardiorespiratory examinations and no rashes. Investigations demonstrated an acute kidney injury (AKI) (creatinine [Cr] 250 micromol/L, N = 60–105 micromol/L), leukocytosis (17.2 x10⁹/L, N = 1.9–7.5 x10⁹/L) with neutrophilia (12.4 x10⁹/L, N = 1.9–7.5 x10⁹/L) and elevated C-reactive protein (22mg/L, N <8mg/L). Elevated lactate levels were observed on admission, which quickly normalised and remained stable. Ceftriaxone and acyclovir were given as empiric cover for meningoencephalitis, levetiracetam and phenytoin as anti-epileptics, as well as ketamine, quetiapine and haloperidol for agitation.
ECG the following day demonstrated sinus rhythm with a newly prolonged corrected QT interval (QTc) and global T-wave inversion, presumed to be medication related (Figure 1 and 2). Over subsequent days he remained agitated, requiring intermittent sedatives and on-going cardiac monitoring. A progressive AKI (Cr 713 micromol/L) was observed. As urinalysis was not performed, the exact trigger remains uncertain, however rhabdomyolysis is considered the most likely cause based on the presentation and associated elevation in creatine kinase (CK 2077 U/L).
View Figure 1–3.
Day-5 ECG demonstrated dynamic inferolateral ST-elevation, with reciprocal ST-depression without haemodynamic compromise (Figure 3). CT head excluded ICH or hydrocephalus. Urgent echocardiogram demonstrated normal biventricular size and systolic function, normal valves, and no features of Takotsubo cardiomyopathy. There was no significant metabolic acidosis or electrolyte derangement noted. High-sensitivity troponin-I, not previously measured, was elevated (498ng/L, N <20ng/L).
Dual anti-platelet therapy was given, and urgent coronary angiogram demonstrated normal coronary arteries with no evidence of coronary vasospasm at the time of contrast injection. Subsequently, agitation gradually improved with persistent QTc prolongation; AKI steadily improved with fluid rehydration (Cr 116 micromol/L), and anti-epileptic medications were re-introduced with no further seizures observed.
ACS typically relates to atherosclerotic plaque rupture or erosion, with STEMI resulting from complete culprit artery occlusion. It is well documented that other conditions, including acute neurologic events, can give rise to cardiac abnormalities.2,3 The so-called neurogenic stunned myocardium can mimic an ACS presentation, with ischaemic ECG changes (including ST-elevation), elevated troponin and occasionally reduced cardiac function, without significant coronary artery obstruction.5
Seizure patients demonstrating ST-elevation is more rarely described. One case described a 75-year-old woman with known ischaemic heart disease presenting with severe headaches and hypertensive emergency without ICH, complicated by a seizure with acute ST-elevation and troponin rise.6 Coronary angiography demonstrated 80% in-stent restenosis of a prior coronary stent without evidence of thrombus or plaque-rupture on intravascular imaging.6 Her final diagnosis was posterior reversible encephalopathy syndrome secondary to malignant hypertension causing seizures.6
One proposed mechanism for the neuro-cardiac association involves sympathetic overactivity with a catecholamine surge (potentially triggered by illness-related stress) following damage to areas of the brain controlling the autonomic nervous system.7 These excess catecholamines may induce direct cardiotoxicity, or precipitate coronary vasospasm. Similarly, studies report more highly elevated plasma epinephrine and norepinephrine levels being associated with hypertension, ST-segment changes and poorer clinical outcomes.2,8,9 If coronary vasospasm is suspected, specific provocation testing with acetylcholine can be considered.10 CT coronary angiogram can serve as an alternative to invasive angiography for ruling out significant obstructive coronary artery disease (CAD), especially in younger patients with a low risk of CAD. However, for cases where the diagnosis is uncertain and there is clinical urgency due to haemodynamic instability or evidence of ongoing ischaemia, invasive angiography remains the preferred approach.11
In summary, this case demonstrates that ST-elevation can occur following seizures without associated coronary plaque. Though the underlying pathophysiology remains unclear, it may be related to increased circulating catecholamines, and while specific guidelines are lacking, neurogenic stunned myocardium and other stress-induced cardiomyopathies are typically reversible and managed medically.5,12 Clinicians should be alert to this possibility in patients with acute seizure episodes.
Dr Maxine Cooper: Cardiology Services, Wellington Hospital, 49 Riddiford Street, Newtown, Wellington 6021, New Zealand.
Dr Michael Dick: Cardiology Services, Tauranga Hospital, 829 Cameron Road, Tauranga South, Tauranga 3112, New Zealand.
Dr Pradeep Sreekumar: Cardiology Services, Tauranga Hospital, 829 Cameron Road, Tauranga South, Tauranga 3112, New Zealand.
Michael Dick: Cardiology Services, Tauranga Hospital, 829 Cameron Road, Tauranga South, Tauranga 3112. Ph: +64 21 037 8819.
Nil.
1) Legget ME, Cameron VA, Poppe KK, et al. The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS): Design and methodology. Cardiogenics. 2021;11(2):84-97. doi: 10.3390/cardiogenetics11020010.
2) Samuels MA. The brain-heart connection. Circulation. 2007;116(1):77-84. doi: 10.1161/CIRCULATIONAHA.106.678995.
3) Bailey WB, Chaitman BR. Electrocardiographic changes in intracranial hemorrhage mimicking myocardial infarction. N Engl J Med. 2003;349(19):1874-75. doi: 10.1056/NEJM200311063491922.
4) Lwin TS, Mitrakrishnan RN, Farooq M, Alama M. ST-segment elevation myocardial infarction with normal coronary arteries secondary to anterior communicating cerebral artery aneurysmal rupture: a case report. Eur Heart J Case Rep. 2021;5(5):168. doi: 10.1093/ehjcr/ytab168.
5) Biso S, Wongrakpanich S, Agrawal A, et al. A Review of Neurogenic Stunned Myocardium. Cardiovasc Psychiatry Neurol. 2017;2017:5842182. doi: 10.1155/2017/5842182.
6) Mously H, Wazzan M, Alkhathlan AZ, Iyer I. Seizure-Associated ST Elevation Myocardial Infarction in Absence of Plaque Rupture. Case Rep Med. 2018;2018:6186521. doi: 10.1155/2018/6186521.
7) Sun C-H, Ko NU. Cardiac manifestations of acute neurologic lesions. In: Aminoff MJ, Josephson SA, editors. Aminoff’s Neurology and General Medicine. US: Academic Press; 2014. p. 183-198.
8) Benedict CR, Loach AB. Sympathetic nervous system activity in patients with subarachnoid hemorrhage. Stroke. 1978;9(3):237-44. doi: 10.1161/01.str.9.3.237.
9) Schenk EA, Moss AJ. Cardiovascular effects of sustained norepinephrine infusions. II. Morphology. Circ Res. 1966;18(5):605-15. doi: 10.1161/01.res.18.5.605.
10) Gurgoglione FL, Vignali L, Montone RA, et al. Coronary Spasm Testing with Acetylcholine: A Powerful Tool for a Personalised Therapy of Coronary Vasomotor disorders. Life (Basel). 2024;14(3):292. doi: 10.3390/life14030292.
11) Berry C, Kramer CM, Kunadian V, et al. Great debate: Computed tomography coronary angiography should be the initial diagnostic test in suspected angina. Eur Heart J. 2023;44(26):2366-2375. doi: 10.1093/eurheartj/ehac597.
12) Liang CW, Chen R, Macri E, Naval N. Preadmission beta-blockers are associated with decreased incidence of neurogenic stunned myocardium in aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2013;22(5):601-7. doi: 10.1016/j.jstrokecerebrovasdis.2011.10.006.
Sign in to view your account and access
the latest publications by the NZMJ.
Don't have an account?
Let's get started with creating an account.
Already have an account?
Become a member to enjoy unlimited digital access and support the ongoing publication of the New Zealand Medical Journal.
The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers. Institutions are encouraged to subscribe. The value of institutional subscriptions is essential to the NZMJ, as supporting a reputable medical journal demonstrates an institution’s commitment to academic excellence and professional development. By continuing to pay for a subscription, institutions signal their support for valuable medical research and contribute to the journal's continued success.
Please email us at nzmj@pmagroup.co.nz